An update on radiation therapy in breast cancer

Hematology/Oncology Clinics of North America

Volumn 13, Issue 2, 1999, Pages 373-389

  Formenti, S ^a   Green, G ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; TUMOR MARKER;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; GENE OVEREXPRESSION; MASTECTOMY; ONCOGENE NEU; PATIENT SELECTION; POSTMENOPAUSE; PRIORITY JOURNAL; RADIATION RESPONSE; REVIEW;

EID: 0033060279     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70061-7     Document Type: Article

References (105)

1. D.L. Ahmann J.R. O'Fallon P.W. Scanlon A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant trial for patients with breast cancer with special emphasis on the aggressiveness of therapy Am J Clin Oncol 5 1982 371
2. AJCC Manual for Staging of Cancer ed 4 1992 J. B. Lippincott Company Philadelphia
3. M. Al-Sarraf M. LeBlanc P.G.S. Giri Superiority of chemoradiotherapy to radiotherapy in patients with locally advanced nasopharyngeal cancer. Preliminary results of an intergroup randomized study Proceedings of the 32nd Annual Meeting of the American Society of Clinical Oncology 15 1996 133
4. Anonymous Meta-analysis–Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy Lancet 339 1992 1
5. R. Arriagada L.E. Rutquist A. Muttson Adequate locoregional treatment for early breast cancer may prevent secondary dissemination J Clin Oncol 13 1995 2869
6. L.J. Ayash A. Elias J. Ibrahim High dose multimodality therapy with autologous stem-cell support in stage IIIB breast carcinoma J Clin Oncol 16 1998 1000
7. J.F. Bishop J. Dewar M.H. Tattersall A randomized phase III study of Paclitaxel (paclitaxel) vs CMFP in untreated patients with metastatic breast cancer Proceedings of the American Society of Oncology 15 1996 114
8. A. Buzdar M.D. McNeese G.N. Hortobagyi Is chemotherapy effective in reducing the local failure in patients with operable breast cancer? Cancer 65 1990 394
9. Buzdar AU, Morris A, Hortobagyi GN, et al: Prospective randomized trial of Taxol (Tax) alone versus fluorouracil, doxorubicin, cyclophosphamide (FAC) as an induction therapy in patients with operable breast cancer. Proceedings of the 33rd Annual Meeting of the American Society of Clinical Oncology #498, 1997
10. A.U. Buzdar S.E. Singletary D.J. Booser Combined modality treatment for Stage III and inflammatory breast cancer Surg Oncol Clin North Am 4 1995 715
11. H. Choy W. Akerley H. Safran Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non–small-cell lung cancer J Clin Oncol 12 1994 2682
12. A.M. Chu K. Kiel Comparison of adjuvant post-operative radiotherapy and multiple drug chemotherapy (CMF-VP) in operable breast cancer patients with more than 4 positive axillary lymph nodes Cancer 50 1982 212
13. S. Ciatto M.R. Del Turco R. Bonardi Non-palpable lesions of the breast detected by mammography–Review of 1182 consecutive histologically confirmed cases Eur J Cancer 30A 1994 40
14. R.M. Clark T. Whelan M. Levine Randomized clinical trial of breast cancer irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update J Natl Cancer Inst 88 1996 1659
15. G. Cocconi B. DiBlasio G. Alberti Problems in evaluating response of primary breast cancer to systemic therapy Breast Cancer Res Treat 4 1984 309
16. G. Crile Jr C.B. Esselstyn Jr Factors influencing local recurrence of cancer after partial mastectomy Cleveland Clin J Med 57 1990 143
17. J. Cuzick H. Steward R. Peto Overview of randomized trials of postoperative adjuvant radiation therapy Cancer Treatment Reports 71 1987 15
18. M. DeLena M. Varini R. Zucali Multimodal treatment for locally advanced breast cancer: Results of chemotherapy-radiotherapy versus chemotherapy-surgery Cancer Clinical Trials 4 1981 229
19. D.D. Dershaw Mammographic detection of breast cancer and preoperative needle localization Semin Surg Oncol 7 1991 247
20. S.W. Dufy L. Tabar G. Fagerberg Breast screening, prognostic factors and survival. Results from the Swedish Two County study Br J Cancer 64 1991 1133
21. Early Breast Cancer Trialists' Cooperative Group Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials N Engl J Med 333 1995 1444
22. S.R. Ebbs J.R. Yarnold Patient and anatomical selectivity in post-operative radiotherapy for early breast cancer: A British prospective Semin Surg Oncol 8 1992 167
23. V. Eusebi E. Feudale M. Foschini Longterm follow-up of in situ carcinoma of the breast Semin Diagn Pathol 11 1994 223
24. L. Feldman G. Hortobagyi A. Buzdar Pathological assessment of response to induction chemotherapy in breast cancer Cancer Res 46 1986 2578
25. I.S. Fentiman C. Poole D. Tong Inadequacy of iridium implant as sole radiation treatment for operable breast cancer Eur J Cancer 32A 1996 608
26. I.S. Fentiman C. Poole D. Tong Iridium implant treatment without external radiotherapy for operable breast cancer: A pilot study Eur J Cancer 27 1991 447
27. B. Fisher S. Anderson C.K. Redmond Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without radiation in the treatment of breast cancer N Engl J Med 333 1995 1456
28. B. Fisher J. Dignam N. Wolmark Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17 J Clin Oncol 16 1998 441
29. E.R. Fisher J. Constantino B. Fisher Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ) Cancer 75 1995 1310
30. E.R. Fisher R. Saas B. Fisher Pathological findings from the National Surgical Adjuvant Breast Project (Protocol 6): Relation of local breast recurrence to multicentricity Cancer 57 1986 1717
31. S.C. Formenti G. Dunnington B. Uzieli Original p53 status predicts for pathological response in locally advanced breast cancer patients treated pre-operatively with continuous infusion 5-fluorouracil and radiation therapy Int J of Radiat Oncol Biol Phys 39 1997 1059
32. Formenti SC, Symmans WS, Volm M, et al: Concurrent paclitaxel and radiation therapy for breast cancer. Seminars in Radiation Oncology, in press
33. S.C. Formenti G. Lucas J.A. Ibarra Initial brachytherapy in the breast conservation approach to breast cancer Am J Clin Oncol 18 1995 2136
34. A.P. Forrest H.J. Stewart D. Everington Randomized control trial of conservation therapy for breast cancer: Six year analysis of the Scottish trial Lancet 348 1996 708
35. B. Fowble A.L. Hanlon D.A. Fein Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS) Int J Radiat Oncol Biol Phys 38 1997 949
36. A. Goldhirsch R.D. Gelber M. Castiglione Relapse of breast cancer after treatment in premenopausal and perimenopausal women: Patterns and prognosis J Clin Oncol 6 1988 89
37. B.J. Haffty D. Fisher J.J. Fisher Regional nodal irradiation in the conservative treatment of breast cancer Int J Radiat Oncol Biol Phys 19 1990 859
38. K.J. Halverson M.E. Taylor C.A. Perez Regional node management and patterns of failure following conservative surgery and radiation therapy for Stage I and II breast cancer Int J Radiat Oncol Biol Phys 26 1993 593
39. J.A. Hayman D.L. Fairclough J.R. Harris Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer J Clin Oncol 15 1997 1252
40. A. Herskovic K. Martz M. Al-Sarraf Combined chemotherapy and radiotherapy compared to radiotherapy alone in patients with carcinoma of the esophagus N Engl J Med 326 1992 1593
41. P.C. Hobar R.C. Jones J. Shouten Multimodality treatment of locally advanced breast cancer Arch Surg 123 1988 951
42. R. Holland S.H.J. Veling M. Mravunac Histological multifocality of TIS, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery Cancer 56 1985 979
43. F.A. Holmes V. Valero J. Walters The MD Anderson Cancer Center experience with Taxol in metastatic breast cancer Monographs National Cancer Institute 15 1993 161
44. G.N. Hortobagyi G.R. Blumenschein W. Spanos Multimodal treatment of locoregionally advanced breast cancer Cancer 51 1983 763
45. P.J. Hoskin B. Rajan S. Ebbs Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer Radiother Oncol 25 1992 83
46. H. Joensuu S. Toikkanen Prognosis of breast cancer with small primary tumour Acta Oncol 30 1991 793
47. Kandioler-Eckersberger D, Taucher S, Steiner B, et al: p53 genotype and major response to anthracyclin or paclitaxel-based neoadjuvant treatment in breast cancer patients [abstract 392]. Proceedings of the 34th Annual Meeting of the American Society of Clinical Oncology. Los Angeles, May 16–19, 1998
48. M. Kauffmann W. Jonar U. Abel Adjuvant randomized trial of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node positive breast cancer J Clin Oncol 11 1993 454
49. D.W. Kinne J.A. Petrek M.P. Osborne Breast carcinoma in situ Arch Surg 124 1986 33
50. R.R. Kuske J.S. Bolton R.M. Wilenzick Brachytherapy as the sole method of breast irradiation in TIS, T1, T2, N0-1 breast cancer Int J Radiat Oncol Biol Phys 30 S1 1994 245
51. M.D. Lagios P.R. Westdahl M.R. Rose The concept and implications of multicentricity in breast carcinoma Pathol Annu 16 1991 83
52. M.D. Lagios P.R. Westdahl F.R. Margolin Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures Cancer 50 1982 1309
53. M.D. Lagios Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment The Breast Journal 1 1995 68
54. D.H. Lau J.K. Ryu D.R. Gandara Twice-weekly paclitaxel and radiation for stage III non–small cell lung cancer Semin Oncol 24 4 Suppl 12 1997 S12 S106
55. J. Liebmann J.A. Cook J. Fisher In vitro studies of taxol as radiation sensitizer in human tumor cells J Natl Cancer Inst 86 1994 441
56. G. Liligren L. Holmberg H. Adami Sector resection with or without postoperative radiotherapy for stage I breast cancer. A randomized trial J Natl Cancer Inst 82 1990 277
57. M.E. Lippman R.A. Sorace C.S. Bagley Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery National Cancer Institute Monographs 1 1986 153
58. C.S. McArdle D. Crawford E.H. Dykes Adjuvant radiotherapy and chemotherapy in breast cancer Br J Surg 73 1986 264
59. B. McCormick P.P. Rosen D. Kinne Duct carcinoma in situ of the breast: An analysis of local control after conservative surgery and radiotherapy Int J Radiat Oncol Biol Phys 21 1991 289
60. S.D. Merajver B.L. Weber R. Cody Breast conservation and prolonged chemotherapy for locally advanced breast cancer: The University of Michigan experience J Clin Oncol 15 1997 2873
61. L. Milas N. Hunter B.L. Kurdoglu Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol Cancer Chemotherapy and Pharmacology 35 1995 297
62. C. Milross K. Mason N. Hunter Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel J Natl Cancer Inst 88 1996 1308
63. I. Mittra D.K. MacRae A meta-analysis of reported correlations between prognostic factors in breast cancer: Does axillary lymph node metastasis represent biology or chronology? Eur J Cancer 12 1991 1574
64. A.D. Morris R.D. Morris J.F. Wilson Breast conserving therapy versus mastectomy in early-stage breast cancer: A meta-analysis of 10 year survival Cancer Journal from Scientific American 3 1997 6
65. H.B. Muss A.D. Thor D.A. Berry c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer N Engl J Med 330 1994 1260
66. J.M. Nabholtz K. Gelmon M. Bontenbal Randomized trial of two doses of paclitaxel in metastatic breast cancer J Clin Oncol 14 1996 1858
67. M. Overgaard S.P. Hansen J. Overgaard Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy N Engl J Med 337 1997 949
68. V.A. Palda H.A. Llewllyn-Thomas R.G. Mackenzie Breast cancer patients' attitudes about rationing post-lumpectomy radiation therapy: Applicability of trade off methods to policy-making J Clin Oncol 15 1997 3192
69. S.L. Parker T. Tong S. Bolden Cancer statistics 1996 CA Cancer J Clin 46 1996 5
70. L.F. Paszat W.J. Mackillop P.A. Groomer Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology and end-result cancer registries J Clin Oncol 16 1998 8
71. M. Perloff G.J. Lesnick A. Korzun Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: A Cancer and Leukemia Group B study J Clin Oncol 6 1988 261
72. M.C. Perry W.L. Eaton K.J. Propert Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung N Engl J Med 316 1987 912
73. L.J. Pierce M. Lippman N. Ben-Baruch The effect of systemic therapy on local-regional control in locally advanced breast cancer Int J Radiat Oncol Biol Phys 23 1992 949
74. J. Ragaz S.M. Jackson N. Le Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med 337 1997 956
75. A. Recht H. Bartelink A. Forquet Post-mastectomy radiotherapy: Questions for the twenty-first century J Clin Oncol 16 1998 8
76. F. Roelofsen J.F. Bosset F. Eschwege Concomitant radiotherapy and chemotherapy superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the EORTC Radiotherapy and Gastrointestinal Cooperative Groups Proceedings of the American Society of Clinical Oncology 14 1995 194
77. P.P. Rosen A.A. Fracchia J.A. Urban “Residual” mammary carcinoma following simulated partial mastectomy Cancer 35 1975 739
78. D. Rosner R.N. Bedwani J. Vana Noninvasive breast carcinoma: Results of a national survey by the American College of Surgeons Ann Surg 192 1980 139
79. R.D. Rubens Management of early breast cancer BMJ 304 1992 1361
80. G.F. Schwartz G.C. Finkel J.C. Garcia Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone Cancer 70 1992 2468
81. G.F. Schwartz C.A. Birchansky L.T. Komarnicky Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast Cancer 73 1994 362
82. C. Shaake-Koning W. Van den Bogaert O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non small cell lung cancer N Engl J Med 326 1992 524
83. M.J. Silverstein B.F. Cohlan E.D. Gierson Duct carcinoma in situ: 227 cases without microinvasion Eur J Cancer 28 1992 630
84. M.J. Silverstein M.D. Lagios P.H. Craig A prognostic index for ductal carcinoma in situ of the breast Cancer 77 1996 2267
85. N. Sneige M.D. McNeese E.N. Atkinson Ductal carcinoma in situ treated with lumpectomy and irradiation: Histopathologic analysis of 49 specimens with emphasis on risk factors and long term results Hum Pathol 26 1995 642
86. L.J. Solin J. Kurtz A. Forquet Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast J Clin Oncol 14 1996 754
87. L.J. Solin I. Yeh J. Kurtz Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment Cancer 71 1993 2532
88. L.J. Solin B. McCormick A. Recht Mammographically detected, clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast conserving surgery and definitive breast irradiation The Cancer Journal from Scientific American 2 1996 158
89. D.E. Sounders D.W. Lawrence C. Christensen Paclitaxel-induced apoptosis in MCF-7 breast cancer cells Int J Cancer 70 1997 214
90. L. Steinberg M. Hassan L. Olmsted A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma Sem Oncol 24 Suppl 19 1997 S19 S51
91. A. Stotter E.N. Atkinson B.A. Fairston Survival following locoregional recurrence after breast conservation therapy for cancer Ann Surg 212 1990 166
92. J.A. Sunshine M.S. Moseley W.S. Fletcher Breast carcinoma in situ: A retrospective review of 112 cases with a minimum 10 year follow-up Am J Surg 150 1985 44
93. S.M. Swain R.A. Sorace C.S. Bagley Neoadjuvant chemotherapy in the combined modality approach of locally advanced non-metastatic breast cancer Cancer Res 47 1987 3889
94. Theriault R, Buzdar AU, Hortobagyi GN, et al: Irradiation (XRT) following mastectomy in patients treated with FAC adjuvant therapy [abstract 381]. Proceedings of the 34th Annual Meeting of the American Society of Clinical Oncology. Los Angeles, May 16–19, 1998
95. E. Touboul L. Buffat J.P. Lefranc Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer Int J Radiat Oncol Biol Phys 34 1996 1019
96. M. Tubiana R. Holland Commission of the European Communities “Europe Against Cancer” Programme. European School of Oncology Advisory Report. Management of non-palpable and small lesions found in mass breast screening Eur J Cancer 30A 1994 538
97. E. Van Limbergen A. Rijnders E. van der Schueren Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedule and surgical treatment techniques on cosmetic results Radiother Oncol 16 1989 253
98. E. Velez-Garcia J.T. Carpenter M. Moore Post-surgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: A South-Eastern Cancer Study Group (SEG) trial Eur J Cancer 28A 1992 1833
99. U. Veronesi A. Luini M. Del Vecchio Radiotherapy after breast preserving surgery in women with localized breast cancer N Engl J Med 382 1993 1587
100. F. Vicini P. Chen P. Benitez Irradiation of the tumor bed alone after lumpectomy in selected patients with early breast cancer treated with breast conserving therapy: Preliminary results of a pilot trial Int J Radiat Oncol Biol Phys 39 1997 293
101. A.F. Wahl K.L. Donaldson C. Fairchild Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis Nat Med 2 1996 72
102. D.E. Wazer J.K. Erban N.J. Robert Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection Cancer 74 1994 878
103. J.S. Wong A.J. Nixon A. Recht Treatment outcome after tangential radiotherapy alone without axillary dissection in patients with early stage breast cancer with clinically negative axillary nodes Int J Radiat Oncol Biol Phys 36 1996 215
104. C.M. Woods J. Zhu P.A. McQueney Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway Mol Med 1 1995 506
105. Zellars R, Clark GM, Allred DC, et al: Prognostic value of p53 for local failure in mastectomy treated breast cancer patients [abstract 401]. Proceedings of the 34th Annual Meeting of the American Society of Clinical Oncology. Los Angeles, May 16–19, 1998